Nordihydroguaiaretic acid en es it fr

Nordihydroguaiaretic acid Brand names, Nordihydroguaiaretic acid Analogs

Nordihydroguaiaretic acid Brand Names Mixture

  • No information avaliable

Nordihydroguaiaretic acid Chemical_Formula

C22H30O3

Nordihydroguaiaretic acid RX_link

http://www.rxlist.com/cgi/generic4/megace_es.htm

Nordihydroguaiaretic acid fda sheet

Nordihydroguaiaretic_acid FDA

Nordihydroguaiaretic acid msds (material safety sheet)

Nordihydroguaiaretic_acid MSDS

Nordihydroguaiaretic acid Synthesis Reference

No information avaliable

Nordihydroguaiaretic acid Molecular Weight

342.472 g/mol

Nordihydroguaiaretic acid Melting Point

218.0-220.0oC

Nordihydroguaiaretic acid H2O Solubility

2 µg/mL (at 37°C for the acetate salt)

Nordihydroguaiaretic acid State

Solid

Nordihydroguaiaretic acid LogP

3.123

Nordihydroguaiaretic acid Dosage Forms

Oral suspension containing 125 mg of megestrol acetate per mL; Tablet

Nordihydroguaiaretic acid Indication

For the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Also used to treat breast cancer, endometrial cancer, and prostate cancer in Canada and some other countries.

Nordihydroguaiaretic acid Pharmacology

Megestrol is a synthetic progestin and has the same physiologic effects as natural progesterone. The precise mechanism of megestrol’s antianorexic and anticachetic effects is unknown. Initially developed as a contraceptive, it was first evaluated in breast cancer treatment in 1967.

Nordihydroguaiaretic acid Absorption

Variable, but well absorbed orally.

Nordihydroguaiaretic acid side effects and Toxicity

No serious unexpected side effects have resulted from studies involving megestrol acetate oral suspension administered in dosages as high as 1200 mg/day.

Nordihydroguaiaretic acid Patient Information

No information avaliable

Nordihydroguaiaretic acid Organisms Affected

Humans and other mammals